We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$104B
AUM Growth
+$704M
Cap. Flow
-$915M
Cap. Flow %
-0.88%
Top 10 Hldgs %
14.25%
Holding
2,771
New
148
Increased
1,779
Reduced
566
Closed
77

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$191M
2
SCHW
Charles Schwab
SCHW
+$157M
3
PFE icon
Pfizer
PFE
+$139M
4
MMM icon
3M
MMM
+$131M
5
META icon
Meta Platforms (Facebook)
META
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 17.28%
2 Financials 14.69%
3 Technology 14.25%
4 Consumer Discretionary 9.55%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYN
1076
DELISTED
CITY NATIONAL CORPORATION
CYN
$3.96M ﹤0.01%
43,776
+4,880
+13% +$451K
TFX icon
1077
Teleflex
TFX
$6.2B
$3.94M ﹤0.01%
29,088
+2,700
+10% +$343K
STLD icon
1078
Steel Dynamics
STLD
$38B
$3.94M ﹤0.01%
190,026
+16,800
+10% +$362K
HLF icon
1079
Herbalife
HLF
$1.33B
$3.92M ﹤0.01%
142,340
-193,026
-58% -$4.67M
HII icon
1080
Huntington Ingalls Industries
HII
$12.7B
$3.92M ﹤0.01%
34,787
-7,580
-18% -$964K
PTLA
1081
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.91M ﹤0.01%
85,797
+68,897
+408% +$2.77M
PB icon
1082
Prosperity Bancshares
PB
$8.98B
$3.88M ﹤0.01%
67,293
+3,997
+6% +$217K
MIC
1083
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$3.88M ﹤0.01%
47,012
+11,713
+33% +$990K
X
1084
DELISTED
US Steel
X
$3.88M ﹤0.01%
188,252
-76,873
-29% -$1.89M
CPRT icon
1085
Copart
CPRT
$27.2B
$3.83M ﹤0.01%
862,664
+327,320
+61% +$1.48M
DSGX icon
1086
Descartes Systems
DSGX
$6.63B
$3.82M ﹤0.01%
238,100
+4,700
+2% +$73K
DNKN
1087
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$3.81M ﹤0.01%
69,359
+5,100
+8% +$264K
ZBRA icon
1088
Zebra Technologies
ZBRA
$17.6B
$3.8M ﹤0.01%
34,241
+6,310
+23% +$655K
ATO icon
1089
Atmos Energy
ATO
$28.8B
$3.78M ﹤0.01%
73,801
+5,300
+8% +$284K
OPLN
1090
Openlane
OPLN
$4.24B
$3.78M ﹤0.01%
266,982
+30,647
+13% +$439K
VC icon
1091
Visteon
VC
$2.81B
$3.78M ﹤0.01%
35,979
+5,163
+17% +$544K
CXRX
1092
DELISTED
Concordia International Corp. Common Stock
CXRX
$3.76M ﹤0.01%
+51,997
New +$3.76M
POR icon
1093
Portland General Electric
POR
$5.89B
$3.74M ﹤0.01%
112,922
+9,490
+9% +$333K
SAGE
1094
DELISTED
Sage Therapeutics
SAGE
$3.74M ﹤0.01%
51,171
+3,071
+6% +$197K
CBSH icon
1095
Commerce Bancshares
CBSH
$8.62B
$3.73M ﹤0.01%
136,591
+10,604
+8% +$275K
DATA
1096
DELISTED
Tableau Software, Inc.
DATA
$3.73M ﹤0.01%
32,304
+8,496
+36% +$918K
ORI icon
1097
Old Republic International
ORI
$10.5B
$3.7M ﹤0.01%
236,912
+18,100
+8% +$279K
SBH icon
1098
Sally Beauty Holdings
SBH
$1.58B
$3.7M ﹤0.01%
117,246
+8,900
+8% +$283K
UE icon
1099
Urban Edge Properties
UE
$2.81B
$3.68M ﹤0.01%
177,104
+16,739
+10% +$377K
ARMH
1100
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$3.68M ﹤0.01%
74,729
+13,943
+23% +$725K

Similar funds

UBS AM's Q2 2015 Portfolio in Review

As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
  • UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
  • UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
  • UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
  • UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
  • UBS AM opened 148 new positions and closed 77 in Q2 2015.
  • UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.

Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.